Please use this identifier to cite or link to this item: https://olympias.lib.uoi.gr/jspui/handle/123456789/19093
Full metadata record
DC FieldValueLanguage
dc.contributor.authorZalavras Ch, G.en
dc.contributor.authorGiotopoulou, S.en
dc.contributor.authorDokou, E.en
dc.contributor.authorMitsis, M.en
dc.contributor.authorIoannou, H. V.en
dc.contributor.authorTsaousi, C.en
dc.contributor.authorTzolou, A.en
dc.contributor.authorKolaitis, N.en
dc.contributor.authorVartholomatos, G.en
dc.date.accessioned2015-11-24T18:56:47Z-
dc.date.available2015-11-24T18:56:47Z-
dc.identifier.issn0392-9590-
dc.identifier.urihttps://olympias.lib.uoi.gr/jspui/handle/123456789/19093-
dc.rightsDefault Licence-
dc.subjectCase-Control Studiesen
dc.subjectEuropean Continental Ancestry Group/geneticsen
dc.subjectFemaleen
dc.subjectGenotypeen
dc.subjectGreece/epidemiologyen
dc.subjectHumansen
dc.subjectMaleen
dc.subjectMiddle Ageden
dc.subject*Mutationen
dc.subjectPolymerase Chain Reactionen
dc.subjectPrevalenceen
dc.subjectProthrombin/*geneticsen
dc.subjectRisk Factorsen
dc.subjectVenous Thrombosis/epidemiology/*geneticsen
dc.titlePrevalence of the G20210A prothrombin gene mutation in Northwestern Greece and association with venous thromboembolismen
heal.typejournalArticle-
heal.type.enJournal articleen
heal.type.elΆρθρο Περιοδικούel
heal.identifier.secondaryhttp://www.ncbi.nlm.nih.gov/pubmed/12771857-
heal.languageen-
heal.accesscampus-
heal.recordProviderΠανεπιστήμιο Ιωαννίνων. Σχολή Επιστημών Υγείας. Τμήμα Ιατρικήςel
heal.publicationDate2003-
heal.abstractAIM: The G20210A mutation of the prothrombin gene is a genetic risk factor for venous thromboembolism (VTE). Variability exists in the mutation prevalence in both normal individuals and VTE patients. The aim of this study was to determine the mutation prevalence in Northwestern Greece and evaluate its association with VTE. METHODS: Presence of the G20210A mutation was investigated using DNA analysis in 176 consecutive patients with a history of venous thrombosis or pulmonary embolism and in 300 healthy controls, all Caucasian residents of Northwestern Greece. RESULTS: The mutation was present 12 patients (6.8%) and 8 controls (2.7%). The odds ratio for presence of the mutation versus the normal genotype in VTE was 2.7 (95% CI: 1.1 to 6.7), which was statistically significant. The prevalence of the G20210A prothrombin gene mutation in Northwestern Greece is 2.7% (95% CI: 0.8% to 4.4%) with an allele frequency of 1.3% (95% CI: 0.4% to 2.3%). CONCLUSION: The G20210A mutation of the prothrombin gene is associated with VTE in the Caucasian residents of this geographic region.en
heal.journalNameInt Angiolen
heal.journalTypepeer-reviewed-
heal.fullTextAvailabilityTRUE-
Appears in Collections:Άρθρα σε επιστημονικά περιοδικά ( Ανοικτά) - ΙΑΤ

Files in This Item:
There are no files associated with this item.


This item is licensed under a Creative Commons License Creative Commons